Dravet Syndrome synonyms

Dravet Syndrome is most commonly referred to by its modern name, though it was historically known as Severe Myoclonic Epilepsy of Infancy (SMEI). Today, the medical community standardizes the term Dravet Syndrome to honor Dr. Charlotte Dravet, who first described the condition in 1978, while synonyms like SMEI remain common in older medical literature and specific clinical databases.

What are the historical and alternative names for Dravet Syndrome?

When reviewing older medical records or international clinical literature, you may encounter several terms used to describe Dravet Syndrome. Historically, the condition was widely classified as Severe Myoclonic Epilepsy of Infancy (SMEI). This name was descriptive of the prominent, often treatment-resistant, myoclonic seizures that occur early in the disease’s progression. Additionally, you may see it referred to as Intractable Epilepsy of Infancy or Polymorphic Epilepsy of Infancy. While these terms are rarely used in modern clinical practice, they persist in archived research papers and legacy electronic health records.

Why does Dravet Syndrome have multiple names?

The evolution of the terminology for Dravet Syndrome reflects the refinement of our medical understanding. Initially, researchers focused on the symptom profile—specifically the severe myoclonic seizures—which led to the name SMEI. However, as clinicians and geneticists discovered that the clinical presentation of Dravet Syndrome is broader than just myoclonic seizures, the medical community moved toward an eponym. Naming the condition after Dr. Charlotte Dravet acknowledges her pioneering work in identifying this specific epilepsy spectrum. This shift also helps avoid confusion with other forms of infantile epilepsy that may share some, but not all, of the clinical features of Dravet Syndrome.

How is Dravet Syndrome classified in medical systems?

Standardized medical classification systems are essential for ensuring consistency in diagnosis and research. Currently, Dravet Syndrome is formally recognized under the following identifiers:

• Orphanet: ORPHA:33090


• OMIM (Online Mendelian Inheritance in Man): #607208


• ICD-10/11: Often coded under G40.4 (Other generalized epilepsy and syndromes) or specific genetic epilepsy categories.

Which name is preferred by medical professionals today?

Today, Dravet Syndrome is the universally accepted term preferred by neurologists, epileptologists, and geneticists worldwide. Using this specific name is crucial for accessing the most current clinical guidelines, treatment protocols, and research initiatives. Within the DiseaseMaps.org community, where 453 people with Dravet Syndrome have shared their experiences, this consistent terminology helps families connect with others who have the same genetic profile and clinical challenges.

Next steps

• Consult a board-certified pediatric neurologist or an epileptologist to confirm your diagnosis and discuss the most current treatment options.


• Verify that your medical records use the term Dravet Syndrome to ensure seamless coordination between specialists.


• Join the DiseaseMaps.org community to connect with other families and access shared resources from those navigating this journey.


• Visit the Dravet Syndrome Foundation website for the latest updates on clinical trials and research advancements.

Medical disclaimer: This content is for educational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• Orphanet (ORPHA:33090): Dravet Syndrome.


• NIH Genetic and Rare Diseases Information Center (GARD): Dravet Syndrome.


• OMIM (Online Mendelian Inheritance in Man): Entry #607208.


• Dravet Syndrome Foundation: Official clinical definitions and patient resources.